Dr. Steingo CV

Brian Steingo, MD


University of the Witwatersrand, Johannesburg, South Africa
Bachelor of Science, Microbiology, Biochemistry, 1968

University of the Witwatersrand Johannesburg, South Africa
Doctor of Medicine, 1971

Johannesburg General Hospital, Johannesburg, South Africa
Internship in Medicine, 1972

Johannesburg Hospitals Complex, Johannesburg, South Africa
Department of Neurology, January 1973 – June 1973
Department of Pediatrics, July 1971 – December 1973
Department of Internal Medicine, 1974 – 1975
Medical Resident Teaching Program Coordinator, 1974 – 1976

Medical University of South Carolina, Charleston, SC
Department of Neurology, April 1977 – June 1978

Baylor College of Medicine, Houston, TX
Department of Neurology, July 1978 – June 1980
Chief Resident, July 1978 – July 1979

University of the Witwatersrand, Johannesburg, South Africa
Bachelor of Science,   Microbiology, Biochemistry, 1968

American Board of Psychiatry & Neurology
Diplomate in Neurology,  May 1983

Florida   ME 36908

Imperial Point Medical Center
6401 North Federal Highway
Fort Lauderdale, FL  33308

CITI TRAINING  – 3/12/2014

American Academy of Neurology
Broward County Medical Association
Florida Medical Association

Infinity Clinical Research, LLC
3537 North Pine Island Road
Sunrise, FL  33351
Principal Investigator, 01/15 – Present

Sunrise Medical Group
3540 North Pine Island Road
Sunrise, FL  33351
Clinical Neurologist, 09/14 – Present

Infinity Clinical Research, LLC
(Formerly:  Multiple Sclerosis Research Associates, PLLC)
(dba Neurological Associates)
572 East McNab Road, Suite 202
Pompano Beach, FL  33060
Principal Investigator, 01/12 – 12/14

Sunrise Medical Group, Inc.
572 East McNab Road, Suite 200
Pompano Beach, FL  33060
Clinical Neurologist, 12/04 – 12/14

MS Center of Fort Lauderdale
(formerly – MS Clinic at North Ridge NeuroScience Center)
572 East McNab Road, Suite 202
Pompano Beach, FL  33060
Director, 1998 – Present

Steingo & Kishner, MD, PA
North Ridge NeuroScience Center
5757 North Dixie Highway
Fort Lauderdale, AL  33334
Clinical Neurologist, 1998 – 12/2004

Steingo & Kishner, MD, PA
5333 North Dixie Highway
Fort Lauderdale, FL  33334
Clinical Neurologist, 1984 – 1997

National MS Society
National Advisory Board Member, 2004-Present

National MS Society, South Florida Chapter
Professional Advisory Committee Member, 1989 – 1997
Chairman, 1997 – Present
Board of Trustees, Member, 1995 – Present
Service & Education Committee Chairman, 1993 – 1997

Attending physician for neurology residents, Nova Southeastern University, Fort Lauderdale, FL – Current

Calkwood, J., Cree, B., Crayton, H.,  Kantor, D., Steingo, B., Barbato,L., Hashmonay, R., Agashivala, N.,  McCague, K., Tenenbaum, N. and Edwards, K. (2014) Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient and physician reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial. BMC Neurology.  14:220

Cree, B. A., Steingo, B. (2012) Emerging challenges on the therapeutic landscape of multiple sclerosis: The managed care physician’s perspective and medical director’s perspective. Journal of Managed Care Medicine. Vol.15, No.4

Ortega, M., Usmani  N., Parra-Herran, C., Adams, D., Steingo, B., Rammohan, K. (2012) CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma. Neurology 79:715-716

Saffer, D. S., Steingo, B., Bill P. L.  (1977). The diagnosis and significance of isolated third nerve palsy in the African. Trop Geogr Med. Jun; 29(2):155-8

Saffer, D. S., Nathan D.C., Kahle P. A. , Steingo B. (1974). Huntington’s disease in a Coloured family. S Afr Med J. Nov 30; 48(58):2399–2402

RECENT PRESENTATIONS:The Multiple Sclerosis Association of America, (2009-2014):
“Charting Your Multiple Sclerosis Treatment Course: An Update on MS Therapies and Research.”
“How to S.E.A.R.C.H. for the Right MS Therapy for You!”
“MS in the Twenty-First Century- Moving Forward.”

NAMCP, Las Vegas, Nevada  (November 2011):
“New and Evolving Therapies in Multiple Sclerosis: The Managed Care Perspective.”

Symposiums for Managed Care Physicians: Pasadena, New York City, San Francisco, Chicago, Philadelphia, Boston (2012 and 2013):  “Multiple Sclerosis in the Managed Care Setting.”

Prime CME Faculty: Multiple Presentations

CME Panel Philadelphia, May 2014. (Sponsored by CMEducation)

Speaker and consultant for multiple pharma companies including  Acorda, Biogen, Genzyme, Pfizer, Questcor, Serono and TEVA.

RESEARCH EXPERIENCE:   Provided upon request